Projects per year
Personal profile
Keywords
- Molecular medicine
- Cancer
- Kidneys and urinary tract
- Genetics
- Digestive tract
- Biochemistry
Fingerprint
Dive into the research topics where Torben Falck Ørntoft is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Analyse af personlige genomiske rearrangementer (PAGER) til kontrol af patienter med blærekræft
Birkenkamp-Demtröder, K. (Participant), Dyrskjøt, L. (Participant), Nordentoft, I. K. (Participant), Jensen, J. B. (Participant), Agerbæk, M. (Participant) & Ørntoft, T. F. (Participant)
02/01/2013 → …
Project: Research
-
Molekylære forandringer i klinisk blærekræft
Birkenkamp-Demtröder, K. (Participant), Nordentoft, I. K. (Participant), Dyrskjøt, L. (Participant) & Ørntoft, T. F. (Participant)
01/01/2011 → …
Project: Research
-
Performance of the Colorectal cancer Screening marker Sept9 is influenced by Age, Diabetes and Arthritis: a nested case-control study
Ørntoft, M. W. (Participant), Andersen, C. L. (Participant), Nielsen, H. J. (Participant) & Ørntoft, T. F. (Participant)
01/12/2015 → 01/12/2016
Project: Research
-
NoCRC: Identification of novel screening markers for Colorectal cancer - NoCRC
Ørntoft, M.-B. W. (Participant), Jensen, S. Ø. (Participant), Bramsen, J. B. (Participant), Andersen, C. L. (Participant), Ørntoft, T. F. (Participant), Velculesco, V. (Participant), Nielsen, H. J. (Participant) & Beck, S. (Participant)
01/01/2014 → 01/01/2018
Project: Research
-
Defining the Role of Organic Cation Transporters in Diabetes Treatment 5.000.000 DKK - Novo Nordisk Fonden
Jessen, N. (Participant), Frøkiær, J. (Participant), Jakobsen, S. (Participant), Ørntoft, T. F. (Participant), Brøsen, K. (Participant) & Grønbæk, H. (Participant)
01/05/2013 → 30/04/2018
Project: Research
Research output
-
The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial
Fredsøe, J., Koetsenruijter, J., Vedsted, P., Kirkegaard, P., Væth, M., Edwards, A., Ørntoft, T. F., Sørensen, K. D. & Bro, F., 2020, In: PLOS Medicine. 17, 2, p. e1003033 14 p., e1003033.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access -
Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer
Bjerre, M. T., Strand, S. H., Nørgaard, M., Kristensen, H., Rasmussen, A. K., Mortensen, M. M., Fredsøe, J., Mouritzen, P., Ulhøi, B., Ørntoft, T., Borre, M. & Sørensen, K. D., Mar 2019, In: International Journal of Molecular Sciences . 20, 5, 1173.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Open Access -
A five-microRNA model (pCaP) for predicting prostate cancer aggressiveness using cell-free urine
Fredsøe, J., Rasmussen, A. K. I., Mouritzen, P., Borre, M., Ørntoft, T. & Sørensen, K. D., 1 Nov 2019, In: International Journal of Cancer. 145, 9, p. 2558-2567 10 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
-
A novel combined miRNA and methylation marker panel (miMe) for prediction of prostate cancer outcome after radical prostatectomy
Strand, S. H., Bavafaye-Haghighi, E., Kristensen, H., Rasmussen, A. K., Hoyer, S., Borre, M., Mouritzen, P., Besenbacher, S., Orntoft, T. F. & Sorensen, K. D., 2019, In: International Journal of Cancer. 145, 12, p. 3445-3452 8 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
-
Independent Validation of a Diagnostic Noninvasive 3-MicroRNA Ratio Model (uCaP) for Prostate Cancer in Cell-Free Urine
Fredsøe, J., Rasmussen, A. K. I., Laursen, E. B., Cai, Y., Howard, K. A., Pedersen, B. G., Borre, M., Mouritzen, P., Òrntoft, T. & Sørensen, K. D., Apr 2019, In: Clinical Chemistry. 65, 4, p. 540-548 9 p.Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Journal article › Research › peer-review
Activities
-
International Symposium on miRNA Cancer Biomarker Research 2016
Torben Falck Ørntoft (Participant)
9 Nov 2016 → 10 Nov 2016Activity: Participating in or organising an event types › Participation in or organisation af a conference
-
The use of miRNA´s for Diagnosis and Classification of Cancer Patients in Precision Medicine; Examples from Prostate, Bladder and Colon
Torben Falck Ørntoft (Lecturer)
9 Nov 2016Activity: Talk or presentation types › Lecture and oral contribution
-
Genetisk Teknologi i Medicinsk Perspektiv: Hvad er de kliniske muligheder ved anvendelse af genetikken?
Torben Falck Ørntoft (Lecturer)
18 May 2016Activity: Talk or presentation types › Lecture and oral contribution
-
Molekylær Forandringer cancer, ancestrale drivere og mutationer-udnyttelse af disse til stratifikation af patienter med ekspressionsprofilering og epigenetiske markører
Torben Falck Ørntoft (Lecturer)
2 Nov 2015Activity: Talk or presentation types › Lecture and oral contribution
-
Precision Medicine based on Genomic-insight, examples from cancer, cardiology and endocrinology
Torben Falck Ørntoft (Lecturer)
2 Sept 2015Activity: Talk or presentation types › Lecture and oral contribution
Prizes
-
Honorary Award
Ørntoft, Torben Falck (Recipient), 1 Jan 2005
Prize: Prizes, scholarships, distinctions